Generation Bio is harnessing non-viral genetic medicine technologies to develop targeted treatments for a variety of diseases. Their unique ctLNP delivery system and innovative RES manufacturing process underscore their commitment to advancing genomic medicine with scalable solutions. This focus not only marks them as a leader in the biotechnology field but also creates a dynamic and technically stimulating environment that continually pushes the boundaries of genetic therapies.